Global Longlife Hospital and Research Ratios

Global Longlife Hospital and Research Ltd Ratios

The Global Longlife Hospital and Research Ltd Ratios page provides a complete fundamental analysis of Global Longlife Hospital and Research Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Global Longlife Hospital and Research Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Global Longlife Hospital and Research Ltd (NSE: , BSE: 543520) is currently trading at ₹14.48, with a market capitalization of ₹152.04M. As a major player in the Health services sector and Hospital/Nursing management industry, Global Longlife Hospital and Research Ltd remains a key stock for fundamental analysis using Global Longlife Hospital and Research Ltd Ratios.

Global Longlife Hospital and Research Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Global Longlife Hospital and Research Ltd P/E ratio currently stands at 100.21, making it one of the most tracked metrics in Global Longlife Hospital and Research Ltd Ratios.

Historically, the Global Longlife Hospital and Research Ltd P/E ratio has shown strong fluctuations:

• 2024: 100.21
• 2023: 0
• 2022: 24.95

The rising Global Longlife Hospital and Research Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Global Longlife Hospital and Research Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.74.

Historical P/B trend:

• 2024: 0.74
• 2023: 1.58
• 2022: 0.73

Global Longlife Hospital and Research Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Global Longlife Hospital and Research Ltd P/S ratio currently stands at 34.48, an important part of Global Longlife Hospital and Research Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 34.48
• 2023: 3.03
• 2022: 1.94

The rising Global Longlife Hospital and Research Ltd P/S ratio indicates improved revenue valuation by investors.

Global Longlife Hospital and Research Ltd Price to Cash Flow Ratio (P/CF)

The Global Longlife Hospital and Research Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 1.64.

Historical Global Longlife Hospital and Research Ltd Price to Cash Flow Ratio:

• 2024: 1.64
• 2023: 0
• 2022: 0

The rising Global Longlife Hospital and Research Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Global Longlife Hospital and Research Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Global Longlife Hospital and Research Ltd EV currently stands at ₹-16.27M, representing the total company valuation including debt.

Historical EV trend:

• 2024: -16.27M
• 2023: 533.14M
• 2022: 511.75M

Global Longlife Hospital and Research Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Global Longlife Hospital and Research Ltd EV/EBITDA ratio is currently 0, a key metric in Global Longlife Hospital and Research Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 12.53

Stable Global Longlife Hospital and Research Ltd EV/EBITDA indicates balanced valuation.

Global Longlife Hospital and Research Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Global Longlife Hospital and Research Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0.49
• 2022: 0.14

Global Longlife Hospital and Research Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Global Longlife Hospital and Research Ltd ROE currently stands at 0.75%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 0.75
• 2023: -4.85
• 2022: 0

Declining ROE indicates pressure on profitability.

Global Longlife Hospital and Research Ltd Ratios Analysis Summary

The Global Longlife Hospital and Research Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Global Longlife Hospital and Research Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Global Longlife Hospital and Research Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.